Pulmatrix is a clinical stage biotech company that develops inhaled therapies to treat respiratory disease. Their iSPERSE technology enables delivery of small or large molecule drugs to the lungs for local or systemic applications. Some of their products include Pulmazole, an inhaled anti-fungal drug, PUR1800, a narrow spectrum kinase inhibitor, and PUR3100, a treatment for acute migraine.